2024 Speakers
Jeremy Abbate
Scientific American
Congressman Jake Auchincloss
D, MA-04
Virginia Amann
ENTENTE Network
Querida Anderson
McKinsey Global Publishing
Matthew Arnold
Clarivate
Jenna Aronson
Two Bear Capital
Irina Babina
Concr
Ross Barrett
Cancer Focus Fund
Max Bayer
Endpoints News
Dawn Bell
Antlia Bioscience, Inc.
Vinona Bhatia
P4CI Partnering for Cancer Innovation
Jennifer Hawks Bland
NewYorkBIO
Laurence Blumberg
Weill Cornell Medicine
Jeff Bockman
Lumanity
Paul Bresge
Ray Therapeutics
Steve Brozak
WBB Securities
Hilary Brueck
Business Insider
Dianna Budgeon
knownwell
Jay Campbell
Cancer Research Institute (CRI)
Lynda Chin
Apricity Health
Wade Davis
Moderna (via Zoom)
David de Graaf
Reverb Therapeutics
Jessica Federer
Angelini Ventures
Seth Flaum
Wilson Sonsini
Manfred Franke
Neuronoff
Alexey Galda
Moderna
Jacob Gottlieb
Altium Capital Management
Daina Graybosch
Leerink Partners
Walter Greenleaf
Stanford University
Kimberly Ha
KKH Advisors
Kurt Haggstrom
Synchron
Karen Harris
The Alzheimer’s Drug Discovery Foundation (ADDF)
Matthew Harrison
Morgan Stanley
Xiaorong He
Boehringer Ingelheim Pharmaceuticals, Inc.
Susan Hockfield
MIT
Christian Howell
Cognito Therapeutics
Nouhad Husseini
Regeneron Pharmaceuticals
Thomas Ichim
Immorta Bio
Sophie Jones
JPMorgan Healthcare Investment Bank
Sari Kaganoff
Rock Health
Konstantina Katcheves
Teva Pharmaceuticals
Manolis Kellis
Massachusetts Institute of Technology (MIT)
Parastoo Khoshakhlagh
GC Therapeutics
Minji Kim
Mineralys Therapeutics, Inc.
Dan Knecht
CVS Caremark
Daniella Kranjac
Avant Bio
Seema Kumar
Cure.
Jonathan Leff
Deerfield, Deerfield Institute
Yaakov Levine
SetPoint Medical
Philippe Lopes-Fernandes
Ipsen
Sean Lorenz
Altoida
Ana Maiques
Neuroelectrics
Maite Malet
Asabys Partners
Neal Masia
EntityRisk
Nathan McBride
Xilio Therapeutics
Ashley Mishoe
PharmaLogic Holdings
Remo Moomiaie-Qajar
Cytonus Therapeutics, Inc
Tim Opler
Stifel
Art Pappas
Pappas Capital
Viq Pervaaz
New York City Economic Development Corporation
Sergei Petukhov
Ludicrous Ventures
Friso Postma
BioXcel Therapeutics
Shri Raghunathan
Noctrix Health
Naveen Rao
Neurotech Futures
Georgia Ravitz
Orrick
Bill Riddoch
BWXT Medical
Kate Rochlin
IN8bio
Beth Rogozinski
Oncoustics
Lexi Rovner
64x Bio
Peter Rubin
No Patient Left Behind
Nabiha Saklayen
Cellino
Ed Saltzman
Lumanity
Sony Salzman
ABC News
Joel Sandler
Ipsos Advisory Healthcare
George Santo
J.P. Morgan
Keara Sauber
Sauber Capital
Sloan Saunders
FlyteHealth
Alison Schecter
Molecules to Medicine Advisory Group
Robert Schneider
Regerna Therapeutics, NYU Grossman School of Medicine
Kfir Schreiber
DeepCure
David Schull
Russo Partners
Stacey Seltzer
Pontiva Healthcare Partners
Thomas Seoh
Kinexum Services
Evonne Sepsis
ESC Advisors
Joseph Shonkwiler
Advanced Research Projects Agency for Health (ARPA-H)
Greg Simon
Simonovation, LLC
Ajit Singh
Artiman Ventures
Thijs Spoor
Perspective Therapeutics
Lawrence Steinman
Beckman Center for Molecular Medicine, Stanford University (via Zoom)
Stephen Thau
Orrick
Uduak Thomas
Genetic Engineering & Biotechnology News
Kevin Tracey
Feinstein Institutes for Medical Research at Northwell Health
Thom Tulip
Radiopharm Theranostics
Arda Ural
Ernst & Young LLP
Brent Vaughan
Founder, Stealth TechBio
Geeta Vemuri
Agent Capital
Stella Vnook
Kaida BioPharma
Adam Wolfberg
Virta Health
Lei Lei Wu
Endpoints News
Rich Yang
Biolinq
Tingting Zhang-Kharas
JLABS US Northeast, Johnson & Johnson Innovation